PMC:7228307 / 52503-52707
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1066 | 135-139 | Gene | denotes | FcγR | Gene:2213 |
| 1068 | 74-78 | Gene | denotes | FcγR | Gene:2213 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T407 | 45-55 | Body_part | denotes | amino acid | http://purl.org/sig/ont/fma/fma82739 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T886 | 0-1 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T887 | 20-23 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T888 | 45-64 | http://purl.obolibrary.org/obo/CHEBI_33708 | denotes | amino acid residues |
| T889 | 45-64 | http://purl.obolibrary.org/obo/PR_000036907 | denotes | amino acid residues |
| T890 | 74-76 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
| T891 | 135-137 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T5000 | 45-55 | Chemical | denotes | amino acid | http://purl.obolibrary.org/obo/CHEBI_33709 |
| T20266 | 45-50 | Chemical | denotes | amino | http://purl.obolibrary.org/obo/CHEBI_46882 |
| T44260 | 51-55 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
LitCovid-sample-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T57 | 45-55 | Chemical | denotes | amino acid | http://purl.obolibrary.org/obo/CHEBI_33709 |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 1066 | 135-139 | Gene | denotes | FcγR | Gene:2213 |
| 1068 | 74-78 | Gene | denotes | FcγR | Gene:2213 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T299 | 0-204 | Sentence | denotes | A separate strategy has used combinations of amino acid residues from the FcγR‐binding regions of IgG2 and IgG4, which have restricted FcγR specificity, together with other binding‐inactivating mutations. |
LitCovid-sample-PD-FMA
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T406 | 45-55 | Body_part | denotes | amino acid | http://purl.org/sig/ont/fma/fma82739 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T299 | 0-204 | Sentence | denotes | A separate strategy has used combinations of amino acid residues from the FcγR‐binding regions of IgG2 and IgG4, which have restricted FcγR specificity, together with other binding‐inactivating mutations. |